Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1961 1
1962 1
1964 2
1965 3
1967 1
1968 5
1969 2
1970 1
1979 2
1980 1
1983 3
1984 3
1985 1
1987 1
1988 2
1989 4
1990 2
1991 9
1992 7
1993 9
1994 9
1995 2
1996 4
1997 4
1998 1
1999 3
2000 4
2001 5
2002 3
2003 4
2004 4
2005 7
2006 5
2007 5
2008 6
2009 2
2010 5
2011 3
2012 5
2013 5
2014 10
2015 11
2016 16
2017 16
2018 8
2019 15
2020 17
2021 17
2022 17
2023 4
Text availability
Article attribute
Article type
Publication date

Search Results

260 results
Results by year
Filters applied: . Clear all
Page 1
Rehabilitation after total joint replacement: a scoping study.
L Snell D, Hipango J, Sinnott KA, Dunn JA, Rothwell A, Hsieh CJ, DeJong G, Hooper G. L Snell D, et al. Among authors: dunn ja. Disabil Rehabil. 2018 Jul;40(14):1718-1731. doi: 10.1080/09638288.2017.1300947. Epub 2017 Mar 23. Disabil Rehabil. 2018. PMID: 28330380 Review.
Comparison of an Oral Factor Xa Inhibitor With Low Molecular Weight Heparin in Patients With Cancer With Venous Thromboembolism: Results of a Randomized Trial (SELECT-D).
Young AM, Marshall A, Thirlwall J, Chapman O, Lokare A, Hill C, Hale D, Dunn JA, Lyman GH, Hutchinson C, MacCallum P, Kakkar A, Hobbs FDR, Petrou S, Dale J, Poole CJ, Maraveyas A, Levine M. Young AM, et al. Among authors: dunn ja. J Clin Oncol. 2018 Jul 10;36(20):2017-2023. doi: 10.1200/JCO.2018.78.8034. Epub 2018 May 10. J Clin Oncol. 2018. PMID: 29746227 Clinical Trial.
Treatment of cancer-associated venous thromboembolism: 12-month outcomes of the placebo versus rivaroxaban randomization of the SELECT-D Trial (SELECT-D: 12m).
Marshall A, Levine M, Hill C, Hale D, Thirlwall J, Wilkie V, French K, Kakkar A, Lokare A, Maraveyas A, Chapman O, Arif A, Petrou S, Maredza M, Hobbs R, Dunn JA, Young AM. Marshall A, et al. Among authors: dunn ja. J Thromb Haemost. 2020 Apr;18(4):905-915. doi: 10.1111/jth.14752. Epub 2020 Feb 26. J Thromb Haemost. 2020. PMID: 31995662 Free article. Clinical Trial.
Levofloxacin prophylaxis in patients with newly diagnosed myeloma (TEAMM): a multicentre, double-blind, placebo-controlled, randomised, phase 3 trial.
Drayson MT, Bowcock S, Planche T, Iqbal G, Pratt G, Yong K, Wood J, Raynes K, Higgins H, Dawkins B, Meads D, Hulme CT, Monahan I, Karunanithi K, Dignum H, Belsham E, Neilson J, Harrison B, Lokare A, Campbell G, Hamblin M, Hawkey P, Whittaker AC, Low E, Dunn JA; TEAMM Trial Management Group and Trial Investigators. Drayson MT, et al. Among authors: dunn ja. Lancet Oncol. 2019 Dec;20(12):1760-1772. doi: 10.1016/S1470-2045(19)30506-6. Epub 2019 Oct 23. Lancet Oncol. 2019. PMID: 31668592 Free PMC article. Clinical Trial.
6 versus 12 months of adjuvant trastuzumab for HER2-positive early breast cancer (PERSEPHONE): 4-year disease-free survival results of a randomised phase 3 non-inferiority trial.
Earl HM, Hiller L, Vallier AL, Loi S, McAdam K, Hughes-Davies L, Harnett AN, Ah-See ML, Simcock R, Rea D, Raj S, Woodings P, Harries M, Howe D, Raynes K, Higgins HB, Wilcox M, Plummer C, Mansi J, Gounaris I, Mahler-Araujo B, Provenzano E, Chhabra A, Abraham JE, Caldas C, Hall PS, McCabe C, Hulme C, Miles D, Wardley AM, Cameron DA, Dunn JA; PERSEPHONE Steering Committee and Trial Investigators. Earl HM, et al. Among authors: dunn ja. Lancet. 2019 Jun 29;393(10191):2599-2612. doi: 10.1016/S0140-6736(19)30650-6. Epub 2019 Jun 6. Lancet. 2019. PMID: 31178152 Free PMC article. Clinical Trial.
DNA motifs suppressing TLR9 responses.
Trieu A, Roberts TL, Dunn JA, Sweet MJ, Stacey KJ. Trieu A, et al. Among authors: dunn ja. Crit Rev Immunol. 2006;26(6):527-44. doi: 10.1615/critrevimmunol.v26.i6.50. Crit Rev Immunol. 2006. PMID: 17341193 Review.
Follow-up in early breast cancer--a surgical and radiological perceptive.
Dunn JA, Donnelly PK, Marshall A, Wilcox M, Watson E, Young A, Balmer C, Ramirez M, Hartup S, Maxwell AJ, Evans AJ; Mammo-50 trial management group. Dunn JA, et al. Clin Oncol (R Coll Radiol). 2014 Oct;26(10):625-9. doi: 10.1016/j.clon.2014.06.015. Epub 2014 Jul 17. Clin Oncol (R Coll Radiol). 2014. PMID: 25044293 No abstract available.
260 results